Medroxyprogesterone Acetate Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Aug 31, 2026 · last update Aug 31, 2026
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| PROVERA, Tablet, 10 mg (NDC 0009-0051-01) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026. | Posted Aug 31, 2026 Updated Aug 31, 2026 Discontinued Aug 31, 2026 |
| PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026. | Posted Aug 31, 2026 Updated Aug 31, 2026 Discontinued Aug 31, 2026 |